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Abstract
Neuroticism is a moderately heritable personality trait considered to be a risk factor for developing major depression,
anxiety disorders and dementia. We performed a genome-wide association study in 2,235 participants drawn from a
population-based study of neuroticism, making this the largest association study for neuroticism to date. Neuroticism was
measured by the Eysenck Personality Questionnaire. After Quality Control, we analysed 430,000 autosomal SNPs together
with an additional 1.2 million SNPs imputed with high quality from the Hap Map CEU samples. We found a very small effect
of population stratification, corrected using one principal component, and some cryptic kinship that required no correction.
NKAIN2 showed suggestive evidence of association with neuroticism as a main effect (p,1026) and GPC6 showed
suggestive evidence for interaction with age (p<1027). We found support for one previously-reported association (PDE4D),
but failed to replicate other recent reports. These results suggest common SNP variation does not strongly influence
neuroticism. Our study was powered to detect almost all SNPs explaining at least 2% of heritability, and so our results
effectively exclude the existence of loci having a major effect on neuroticism.
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Introduction
Neuroticism is a personality trait that has been associated with
several psychiatric disorders, and is considered one of the risk
factors for the development of depression, anxiety disorders
[1,2,3,4] and dementia [5]. When measured by the Eysenk
Personality Questionnaire (EPQ) [6], neuroticism has been shown
to be relatively stable, with a stability of 0.62 over 20 years [7],
although there is some evidence of a moderate decline in older
ages [8,9]. Neuroticism is consistently higher in females than males
[10,11], but it is unclear whether this is a direct effect of gender or
a consequence of different environments experienced by males
and females [8,12–14]. The heritability of neuroticism has been
estimated in the range 0.30 to 0.50, based on twin studies [7,15–
17] that also show a genetic covariance of neuroticism with anxiety
and depression [10,13,18–22].
Significant or suggestive linkage has been reported within
regions on chromosomes 1p, 1q, 4q, 6p, 7p, 11p, 11q, 12q, 13q
and 15q [23–26]. Shifman [27] reported a genome-wide
association study for EPQ-N in 2,054 extreme-scoring individuals
from a large cohort (patient registers of UK general practitioners)
using eight DNA pools. No significant SNPs were identified under
linkage peaks derived from sib pairs in the same cohort [14,23].
They reported an association at SNP rs702543, in the phospho-
diesterase 4D gene (PDE4D) on chromosome 5q, but even after
individual genotyping of a further 1534 individuals from the same
cohort, the combined p-value was not genome-wide significant
(p=261026). Further analysis of rs702543 in a combined sample
from three populations (Australian twins, Virginia Adult Twin
registry, Netherlands twin families), using a measure of neuroti-
cism that is similar to EPQ-N, showed a non-significant trend for
an excess of the risk allele (A) in high neuroticism-score
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individuals. A family-based analysis revealed overtransmission of
the A allele in high-score individuals from the Australian sample
(p=0.04), but not in the Netherlands sample. Thus, the association
of rs702543 with neuroticism is notable but requires confirmation.
In a genome-wide study of US-based and German samples, van
den Oord [28] found association between neuroticism and four
SNPs in the chr 14 gene MAMDC1 (combined p,1026). To date,
the most recent association study [29] failed to replicate an
association between the candidate gene NPY and stress response
and emotion (reported by Zhou [30], using instruments other than
the EPQ).
We conducted the largest genome-wide association study to
date, with 2,235 individuals from a population-based collection,
for whom EPQ-N score and 430K SNP genotypes were available.
We also analysed an additional 1.2 M well-imputed SNPs.
Results
The sample consists of individuals who previously participated
in the ‘CoLaus’ study [31] a community survey of 6 738 randomly-
selected residents of the city of Lausanne (Switzerland). Of the 3
400 Caucasians who accepted the psychiatric evaluation (55%
participation rate), 2 239 individuals also completed and returned
the EPQ questionnaire (66% return rate), and had genotype data
available.
The mean age of the study individuals was 51.9 (SD 8.85; range
36–70), and 55.4% were female. These compare with mean age
51.2 (SD 8.82; range 36–70) and 53.0% female among all
3,307 PsyCoLaus individuals, indicating that responders to the
questionnaire are slightly older and more likely to be female than
non-responders.
A QQ plot of the p-values for the genotyped SNPs (supplemen-
tary material File S1) suggested negligible inflation due to
population structure or cryptic relatedness (genomic control
l=1.014), but also little evidence of p-values below those expected
under the null hypothesis. Results from the main-effects analyses are
shown in Figure 1a, and Table 1. Both genotyped and imputed
SNPs within the gene ARRDC4, at the distal end of 15q, almost
reached p=1026. We identified several imputed SNPs with p,1026
on 6q, within the gene NKAIN2, which has not previously been
reported in linkage or association studies, although the strongest
association at a genotyped SNP (rs11154221) in this gene has
p<1024. No SNP showed a notable interaction with sex (Figure 1b).
SNP by age interaction analyses revealed multiple associations at
the distal end of 13q within gene GPC6 (Figure 1c, Table 1). The
strongest signal (p<1027) was at a genotyped SNP, rs9561329; EPQ
Figure 1. P-values over genomic location. -log10(p-value) for association with EPQ-N, against genomic location for 1.7 M genotyped and well-
imputed SNPs. Top: main SNP effect; middle: sex by SNP interaction; bottom: age by SNP interaction.
doi:10.1371/journal.pone.0011504.g001
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score tends to increase with age for carriers of the minor allele, and
decreases for non-carriers (Figure 2). Conditional regression
analyses revealed that the signal at each of the SNPs reported in
Table 1 effectively disappeared when the most strongly-associated
SNP at that locus was included as a predictor in the regression,
suggesting at most one causal variant underlying each signal.
SNP rs702543 in gene PDE4D, reported by Shifman [27] to be
associated with neuroticism, was not present among our 1.7 M
genotyped or imputed SNPs. However, we obtained p=0.006 for
association at the imputed SNP rs296410 that showed the highest
R2 with rs702543 in the Hap Map CEU samples (R2 = 0.51); in
our study, the major allele (T, frequency 0.52) at rs296410 shows a
Table 1. Most significant main effect and interaction results for association with neuroticism (EPQ-N).
SNP main effect, p,2.561026
chr position snp -log10(p-val) Beta (SE) gene Alleles (MAF) genotyped?
6 q21 rs12204812 6.43 20.91 (0.18) NKAIN2 A/C (0.33)
6 q21 rs9491140 6.47 20.91 (0.18) NKAIN2 C/T (0.33)
6 q21 rs9491142 6.45 20.91 (0.18) NKAIN2 A/G (0.33)
6 q21 rs12192208 6.29 20.90 (0.18) NKAIN2 A/C (0.33)
15 q26.3 rs1043372 5.68 20.82 (0.17) ARRDC4 C/T (0.38) Y
15 q26.3 rs1043374 5.75 20.83 (0.17) ARRDC4 C/A (0.38) Y
15 q26.3 rs4965121 5.83 20.84 (0.17) ARRDC4 C/G (0.38)
SNP by Age, p,2.561027
chr position snp -log10(p-val) Beta (SE) gene Alleles (MAF) genotyped?
13 q32 rs2025947 6.74 20.18 (0.03) GPC6 C/T (0.9)
13 q32 rs3814277 6.60 20.17 (0.03) GPC6 C/G (0.1)
13 q32 rs8002366 6.68 20.17 (0.03) GPC6 C/T (0.09)
13 q32 rs9561326 6.64 20.17 (0.03) GPC6 C/T (0.09)
13 q32 rs9561329 6.98 20.17 (0.03) GPC6 A/G (0.09) Y
13 q32 rs9301877 6.72 20.18 (0.03) GPC6 A/G (0.09)
doi:10.1371/journal.pone.0011504.t001
Figure 2. EPQ-N distribution by 3-year age groups according to minor allele carrier status at rs9561329.
doi:10.1371/journal.pone.0011504.g002
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positive linear association with EPQ-N score. We could not
replicate the association found by van den Oord [28] for the gene
MAMDC1 on 14q. Three of the four SNPs they reported had a
perfect proxy in our SNP set, but our lowest p-value in this gene
was p=0.43. We tested 3 genotyped SNPs in the gene NPY studied
by Zhou30, including a SNP, rs16126, in high LD (R2<0.9) with
two of their reported SNPs, but we found p.0.4 at all three SNPs.
Finally, we found no significant enrichment of a GO functional
category among SNPs with p,1024.
A separate analysis was carried out on the X chromosome,
including the pseudo-autosomal region. Genotypes were coded as
0, 1, and 2 for females, and 0 and 2 for males, and sex was
included as a covariate in the linear regression model. No
significant associations were found.
Discussion
We present a comprehensive analysis of a population-based
sample for genome-wide association with neuroticism. The
evidence from 19 cryptic first-degree relative pairs in our study
suggests a heritability for EPQ-N of at most 0.22, lower than the
previously-reported range of 0.3 to 0.5. We identified SNPs in
NKAIN2 showing evidence for an additive main effect, but short of
genome-wide significance. This gene has been linked with
neurological phenotypes [41], though little functional or molecular
information is available. Several SNPs in gene GPC6 on 13q gave a
signal for an interaction with age. GPC6 is known to be involved in
the regulation of the Wnt pathway [42] that plays a role in
intracellular signalling both during neural development [43] and
also in the mature nervous system with possible implication in
synaptic modulation and plasticity. There is some evidence that
abnormalities of signal transduction may be implicated in the
pathophysiology of psychiatric disorders, including mood disorders
and schizophrenia [44,45]. Several studies also suggest that Wnt-
pathway abnormalities may play a role in neurodegenerative
process and Alzheimer disease [46,47]. Neuroticism, alone or in
combination with other personality traits or lifestyle, has been
shown to be predictive for Alzheimer [5,48].
It is difficult to speculate why our novel, population-based
heritability estimate is so much lower than those from previous
family- and studies. Common environment may partly explain a
familial effect that may have been misattributed to genetics. Like
all studies, ours has a number of limitations. The EPQ-N was
assessed from self-administered questionnaires posted back to the
researchers. Only 66% of the eligible subjects sent back the
questionnaire, which may have generated a response bias,
although we have shown that there are only minor differences
in sex and age between responders and non-responders. Our
study has a cross-sectional design, and individuals suffering a
neurological condition such as dementia may be less likely to
complete and return the EPQ. However, all participants in the
PsyCoLaus had a psychiatric assessment and completed a Mini
Mental Stage Examination [49]. If a locus has pleiotropic effects,
affecting both neuroticism and dementia in old age, this could
generate an age-dependent response-bias towards protective
alleles, leading to a genotype by age interaction such as we
observed at GPC6.
Our study was powered to detect almost all SNPs explaining at
least 2% of phenotypic variation, and so our results effectively
exclude the hypothesis that there are major loci affecting
neuroticism in the Lausanne population. The lack of strong
genetic association with EPQ-N score might imply that neurot-
icism is controlled by many loci each of relatively small effect, as is
the case for many other complex phenotypes. There may also be
important environmental interactions with risk factors not
available in our study. If confirmed by additional studies, the
suggestive age by genotype interaction that we report raises
interesting methodological and biological questions.
Materials and Methods
Sample and assessment
The CoLaus was designed to assess cardiovascular disease risk
factors and to collect plasma samples for the study of genetic
variants and biomarkers. The random sampling procedure was
based on a list of Lausanne inhabitants aged 35–75 years (n = 56
694 in 2003), obtained from the population register of the city.
From the original study, all 35 to 66 year-old participants were
invited to participate in the psychiatric arm of the study; for more
details on the rationale, design and methods of the study see
Preisig [32]. All subjects who were sufficiently fluent in French or
English and agreed to participate were included into the
PsyCoLaus sub-study and underwent the psychiatric assessment
between 2004 and 2008. The present analysis was restricted to
Caucasians (92% of the sample). The study was approved by the
Local Ethics Committee and was supported in part by Glax-
oSmithKline. All participants were duly informed about this
sponsorship, and consented for the use of biological samples and
data by GlaxoSmithKline and its subsidiaries.
All the participants were interviewed using the Diagnostic
Interview for Genetic Studies [33] (DIGS), in order to formulate
DSM-IV and subthreshold diagnoses. Additional assessment
included: medical records, family history [Family History-
Research Diagnostic Criteria (FH-RDC) developed by Andreasen
[34]], several self-report questionnaires including EPQ and STAI,
and life events interview.
The EPQ is a 90-item self-report personality inventory [6] that
has been widely used for personality assessment in psychiatry and
other medical fields. Factor analysis of both English and French
versions revealed four dimensions that have been labelled
Extraversion, Neuroticism, Psychoticism, and Social desirability
(Lie scale). Reliabilities of the resulting scales, and correlations
between factors, were found to be similar between English and
French versions. In particular, using three different French
samples, Eysenck [6] reported Cronbach alpha coefficients of
0.78 to 0.87 for neuroticism.
Neuroticism scores range between 0 and 24, with higher scores
indicating more severe neuroticism. See Figure 3 for the
distribution of EPQ-N in our study. The overall mean score was
9.33 (SD 5.61), but there was a highly-significant sex difference
(males: mean 8.17, median 7, SD 5.50; females: mean 10.26,
median 10, SD 5.53; Mann-Whitney test p,10216). There was no
correlation between age and EPQ-N (r =20.02, p = 0.26).
Genotyping and quality controls
Venous blood samples were taken at the time of the
participation in the CoLaus study. Nuclear DNA was extracted
from whole blood. Participants consented for the genetic data to
be used for the study of cardiovascular risk factors and psychiatric
disorders. The samples were genotyped on the Affymetrix
GeneChip Human Mapping 500K Array Set according to the
Affymetrix published protocol. Genotypes were determined by the
Bayesian Robust Linear Model with Mahalanobis Distance
algorithm (BRLMM). Details of the genotyping procedures are
given by Li [35]. A QC procedure was carried out on the sample
to remove SNPs with poor amplification and individuals with an
excess of missing genotypes. First, a total of 60,545 SNPs with
.5% missing genotypes were removed. Next, 4 individuals with
Genetics of Neuroticism
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missingness.5% among the remaining SNPs were excluded. This
left 2,235 individuals genotyped at 430,193 autosomal SNPs. An
additional 9,828 SNPs were available on the X chromosome, but
only in 2,168 individuals. Overall we flagged 1,893 autosomal
SNPs showing significant deviation from HWE (p,1024). None of
the SNPs highlighted here were among these 1,893.
Statistical analysis
Assuming an additive genetic model and a Gaussian-distributed
phenotype, 2 235 individuals provide 95% power to detect a
genotyped SNP with heritability h2 = 0.02 at significance level
561027, and 39% power for h2 = 0.01. Thus we expect to detect
almost all SNPs with h2.0.02 and a large proportion of those with
h2.0.01.
In order to investigate any possible population structure or
cryptic relatedness among our study subjects, we selected a subset
of genotyped SNPs to produce a kinship matrix and perform
Principal Component Analysis (PCA). The SNPs were chosen
using PLINK [36] to have minor allele fraction .5% and
pairwise R2#0.5, in a window size of 50 SNPs sliding 5 SNPs at a
time. This process chose 75,046 SNPs for kinship and PCA
analyses. For these analyses, missing genotypes were replaced
with the mean genotype score for that SNP. The kinship matrix is
K=XXT/2n, where n is the number of SNPs and X is a matrix
with rows corresponding to individuals, while each column
contains the genotype score for a SNP (i.e. the number of copies
of minor allele, 0, 1 or 2), standardised to mean zero and unit
variance. The (i, j) element of K is the excess allele sharing for
alleles drawn from individuals i and j, beyond that expected for
unrelated individuals given the allele fraction estimates [37]. The
eigenvectors of K are the principal components, used to diagnose
and correct for population structure. The first principal
component (PC1) showed some dispersion of individuals away
from the main cluster (Figure 4(b)), which may correspond to
admixture. This was the only one of the first five PCs that was
significantly associated with neuroticism (p,1024), explaining
0.5% of the phenotypic variance. From K we also identified 54
pairs of individuals with kinship estimate .0.05, which
corresponds approximately to at least a cousin relationship in
an outbred population (Figure 4(a)). Of these 54 kin pairs, 19 had
kinships around 0.25, consistent with a first-degree relationship
(sibling, or parent/offspring).
To analyse all the study subjects without having to remove one
of each kin pair, we considered implementing a mixed-regression
association analysis in which phenotypic correlation was propor-
tional to K [38,39], while age and sex were fitted as fixed effects.
The motivation for this model is that any polygenic component of
disease causation should be shared among individuals according to
Figure 3. Distribution of EPQ-N score across the subjects. A: Males. B: Females. C: Both sexes.
doi:10.1371/journal.pone.0011504.g003
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their kinships. However, in fitting the mixed model the maximum
likelihood estimate of the component of variance attributable to
kinship was zero. In fact, among the 19 pairs of apparent first-
degree relatives, the correlation in neuroticism was 20.36, which
leads to an upper 97.5% confidence limit for the heritability of
neuroticism of 0.22. As a consequence of this negative correlation
in our study, there is no inflation of test statistics if we ignore
kinship and analyse all the study subjects using standard linear
regression. After adjusting for age and sex, the EPQ-N score was
close normal (Gaussian) and no transformation was necessary.
The genotypes of 2 149 individuals were imputed at over 2
million SNPs using the CEU HapMap samples and the IMPUTE
program [40]. We retained for analysis the 1 705 237 genotyped
and imputed SNPs with, on average over individuals, probability
$0.9 assigned to their most likely genotype. These were analysed
using a standard linear model implemented in R, with SNP coded
as the expected minor allele count. In addition to PC1, age and sex
were included as covariates in each model, and the interactions of
these terms with the SNP were also tested. The age term used for
the linear model was the age at the time of psychological
assessment, not that at recruitment.
Finally, we used a Gene Ontology (GO) tree machine
(Vanderbilt University) to explore the possible enrichment of any
pre-defined functional category among the genes that included a
SNP with p,1024.
Supporting Information
File S1 LogQQ plot of the p-values of the SNP main effect.
Found at: doi:10.1371/journal.pone.0011504.s001 (5.49 MB
TIF)
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